Objective This study aimed to reveal the clinical significance of the platelet reactivity unit
(PRU) and the efficacy of adjunctive cilostazol and its association with thromboembolic and …

Objectives Low response to antiplatelet drugs is one of the risk factors for ischemic events.
We examined the influence of low response to clopidogrel on symptomatic ischemic events …

BACKGROUND AND PURPOSE: Antiplatelet resistance is known to be associated with
symptomatic ischemic complication after endovascular coil embolization. The purpose of our …

Background Dual antiplatelet therapy for stent-assisted coiling of cerebral aneurysms is
essential to prevent thromboembolic complications. There is concern that Y-stent-assisted …

Purpose To reduce procedural thromboembolisms, tailored antiplatelet drug preparation has
been used according to antiplatelet resistance for endovascular coiling of unruptured …

BACKGROUND AND PURPOSE: Procedure-related thromboembolism is a major limitation
of coil embolization, but the relationship between thromboembolic infarction and antiplatelet …

Background Thromboembolic complications are the primary risks of stent-coiling of cerebral
aneurysms. The utility of platelet function testing in stent-assisted aneurysm coiling remains …

Objective Periprocedural thromboembolic events are a serious complication associated with
coil embolization of unruptured intracranial aneurysms. However, no established clinical …

We aimed to evaluate the correlation between aspirin or clopidogrel resistance and the risk
of thromboembolic events (TEs). Between June 2011 and April 2015, we reviewed clinical …

Objective A retrospective review of premedication method and drug resistance of aspirin and
clopidogrel in association with thromboembolic events during and after coil embolization of …